Urosepsis: from the intensive care viewpoint

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Urology

Background:

• Sepsis and severe sepsis/septic shock affect a significant number of individuals in Germany annually.
• Urosepsis accounts for 7% of sepsis cases, highlighting the need for specific management strategies.
• Early diagnosis of sepsis is critical for timely and effective treatment, directly impacting patient mortality.

Purpose of the Study:

• To review current treatment strategies for urosepsis.
• To emphasize the importance of early diagnosis and intervention in sepsis management.
• To discuss supportive and adjunctive therapies for sepsis and septic shock.

Main Methods:

• Literature review of sepsis and urosepsis treatment guidelines and studies.
• Analysis of supportive therapies including fluid resuscitation, inotropes, and vasopressors.
• Examination of adjunctive therapies such as activated protein C (APC) and hydrocortisone.

Main Results:

• Adequate volume loading and appropriate use of vasopressors are key supportive measures for urosepsis.
• Activated protein C (APC) has demonstrated a decrease in mortality in sepsis patients with organ failure.
• Low-dose hydrocortisone therapy is supported by current data for vasopressor-dependent severe septic shock.

Conclusions:

• Prompt initiation of therapy is paramount for sepsis survival.
• Implementing evidence-based practices into clinical care remains a challenge.
• Comprehensive management of urosepsis involves source control, antimicrobials, and tailored supportive/adjunctive treatments.